There are currently two indicators, Morphine Consumption Data and the Pain Management Index, that have been widely used to assess the efficacy of cancer pain treatment. Both are based on the World Health Organization guidelines for cancer pain and both have limitations in their ability to assess the quality of pain care for cancer patients. The published studies that have used these methods all report that cancer pain is generally undertreated in a wide range of clinical settings and care models.
KrakauerELWenkRBuitragoR. Opioid inaccessibility and its human consequences: reports from the field. J Pain Palliat Care Pharmacother2010; 24: 239–243.
StjernswardJFoleyKMFerrisFD. The public health strategy for palliative care. J Pain Symptom Manage2007; 33: 486–493.
4.
FoleyKM. Acute and chronic cancer pain syndromes. Oxford textbook of palliative medicineNew York: Oxford University Press, 2003; 298–316.
5.
FoleyKMWagnerJLJoransonDE. Pain control for people with cancer and AIDS. Disease control priorities in developing countries2nd ed. New York: Oxford University Press, 2006; 981–994.
6.
ZechDFGrandSLynchJ. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain1995; 63: 65–76.
7.
CleelandCSGoninRHatfieldAK. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med1994; 330: 592–596.
8.
deWitRva DamFAbu-SaadHH. Empirical comparison of commonly used measures to evaluate pain treatment in cancer patients with chronic pain. J Clin Oncol1999; 17: 1280–1287.
9.
CleelandCSGoninRBaezL. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Inter Med1993; 127: 813–816.
10.
LarueFColleauMSBrasseurL. Multicentre study of pain and its treatment in France. Br Med J1995; 310: 1034–1037.
11.
WilsonKGChochinovHMAllardP. Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manage2009; 14: 365–370.
12.
JoransonDERyanKMMauerMA. Opioid policy, availability and access in developing and non-industrialized countries. Bonica’s management of pain20104th ed. New York: Lippincott Williams & Wilkins.
13.
World Health Organization. A community health approach to palliative care for HIV/AIDS and Cancer Patients in sub Saharan AfricaGeneva: World Health Organization, 2003; .
14.
JagweJMerrimanA. Uganda delivering analgesia in rural Africa opioid availability and nurse prescribing. J Pain Symptom Manage2007; 33: 547–551.
15.
RajgopalMJoransonD. India opioid availability an update. J Pain Symptom Manage2007; 33: 610–614.
16.
KrakauerRNgocN. Vietnam: integrating palliative care into HIV and cancer care. J Pain Symptom Manage2007; 33: 578–583.
17.
LohmanDSchleiferRAmonJJ. Access to pain treatment as a human right. BMC Med2010; 8: 8–8.
18.
Human Rights Watch. Unbearable pain: India’s obligation to ensure palliative care. Human Rights Watch Report, 28 October 2009.
19.
World Health Organization. Cancer pain reliefGeneva: World Health Organization, 1986; .
20.
World Health Organization. Cancer pain relief and palliative care in childrenGeneva: World Health Organization, 1998; .
21.
World Health Organization. Cancer pain relief with a guide to opioid availability19962nd ed. Geneva: World Health Organization.
22.
World Health Organization. Cancer pain relief and palliative careGeneva: World Health Organization, 1990; .
23.
VentafriddaVCaraceniAGambaA. Field-testing of the WHO guidelines for cancer pain relief: summary report of demonstration projects. In: FoleyKBonicaJVentafriddaVCallawayM (eds) Second International Congress on Cancer Pain. Advances in pain research and therapyNew York: Raven Press, 1990; Vol 16: 451–451.
24.
DeLimaLKrakauerELLorenzK. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manage2007; 33: 521–527.
25.
CleelandCS. Strategies for improving cancer pain management. J Pain Symptom Manage1993; 8: 1–4.
26.
ClearyJFHudsonPJoransonD. Access to therapeutic opioid medications in Europe by 2011? Fifty years on from the Single Convention on Narcotic Drugs. Palliat Med2010; 24: 109–110.
KrakauerELNgocNTMGreenK. Vietnam: integrating palliative care into HIV/AIDS and cancer care. J Pain Symptom Manage2007; 33: 578–583.
30.
StjernswardJFerrisFDKhleifSN. Jordan palliative care initiative: A WHO demonstration project. J Pain Symptom Manage2007; 33: 628–632.
31.
The SUPPORT Principal Investigators. A controlled trial to improve care for the seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatment (SUPPORT). J Am Med Assoc1995; 274: 1591–1598.
32.
WolfeJGrierHEKlarN. Symptoms and suffering at the end of life in children with cancer. N Engl J Med2000; 345: 326–333.
33.
Addington-HallJMO'CallaghanAC. A comparison of the quality of care provided to cancer patients in the UK in the last three months of life in inpatient hospices compared with hospitals; from the perspective of bereaved relatives: results for a survey using the VOICES questionnaire. Pall Med2009; 23: 190–197.
34.
BernabeirRGambassiGLapaneK. Management of pain in elderly patients with cancer. SAGE Study Group. J Am Med Assoc1998; 279: 1877–1882.
35.
LinJTMatthewP. Cancer pain management in prisons: a survey of primary care practitioners and inmates. J Pain Symptom Manage2005; 29: 466–473.
36.
Brawley OW, Smith De, Kirch RA, et al. Taking action to ease suffering: advanced cancer pain control as a healthcare priority. CA-Cancer J Clinic 2009; 59: 285–289.
37.
Cherny NI, Badelga J, de Conno F, et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 2010; 21: 615–626.
38.
BreivikHChernyNCollettB. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol2009; 20: 1420–1433.
39.
OkayamaTWangXSAkechiT. Adequacy of cancer pain management in a Japanese cancer hospital. Jpn J Clin Oncol2004; 34: 37–42.
40.
DeandreaSMontanariMMojaL. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol2008; 19: 1985–1991.
41.
EntingRHOldenmengerWHVan GoolAR. The effects of analgesic prescription and patient adherence on pain in a Dutch outpatient cancer population. J Pain Symptom Manage2007; 34: 523–531.
42.
FelleiterPGustorffBLierzP. Use of the World Health Organization guidelines on cancer pain relief before referral to a specialized pain service. Schmerz2005; 19: 265–271.
43.
RussellPBAveyardSCOxenhamDR. An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage2006; 32: 581–588.
44.
van den Beuken-van EverdingenMHde RijkeJMKesselsAG. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain2007; 132: 312–320.
45.
ApoloneSCorliOCaraceniA. Cancer Pain Outcome Research Study Group (CPOR-G) investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer2009; 100: 1566–1574.
46.
Krou-MauroAMHirdAWongJ. Has pain management in cancer patients with bone metastases improved? A seven-year review of an outpatient palliative radiotherapy clinic. J Pain Symptom Manage2009; 37: 77–84.
